These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28131519)

  • 1. Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee.
    Miller KL; Puet BL; Roberts A; Hild C; Carter J; Black DL
    J Subst Abuse Treat; 2017 May; 76():36-42. PubMed ID: 28131519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimum methadone compliance testing: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(21):1-54. PubMed ID: 23074492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Substance abuse detection in substitution therapy : Oral fluid versus urine screening].
    Stein J; Geraedts M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1261-1268. PubMed ID: 28929198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
    West R; Mikel C; Hofilena D; Guevara M
    Drug Alcohol Depend; 2018 Dec; 193():183-191. PubMed ID: 30391868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
    Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder.
    Arvidsson M; Ullah S; Franck J; Dahl ML; Beck O
    Drug Test Anal; 2019 Jan; 11(1):27-32. PubMed ID: 29575801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens.
    Heltsley R; Depriest A; Black DL; Crouch DJ; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2012 Mar; 36(2):75-80. PubMed ID: 22337775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of oral fluid in compliance monitoring of opioid medications.
    Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D
    Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
    Cone EJ
    Forensic Sci Int; 2012 Feb; 215(1-3):88-91. PubMed ID: 21377302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive urine drug testing in office-based opioid treatment: a literature review.
    Barthwell AG; Allgaier J; Egli K
    Crit Rev Toxicol; 2018 Nov; 48(10):829-852. PubMed ID: 30794024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
    Truver MT; Palmquist KB; Swortwood MJ
    J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction.
    Kunkel F; Fey E; Borg D; Stripp R; Getto C
    J Opioid Manag; 2015; 11(5):435-42. PubMed ID: 26535971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Urine and Oral Fluid for Workplace Drug Testing.
    Casolin A
    J Anal Toxicol; 2016 Sep; 40(7):479-85. PubMed ID: 27344042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
    Musshoff F; Hokamp EG; Bott U; Madea B
    Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
    Heikman P; Sundström M; Pelander A; Ojanperä I
    Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Drugs in Oral Fluid Samples Using a Commercially Available Collection Device: Agreement with Urine Testing and Evaluation of A and B Samples Obtained from Employees at Different Workplace Settings with Uncontrolled Sampling Procedures.
    Zheng Y; Sparve E; Sparring S; Bergström M
    J Anal Toxicol; 2021 Jan; 44(9):1004-1011. PubMed ID: 32128555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability and accuracy of oral fluid drug testing for patients on methadone maintenance.
    O'Callaghan ME; Regan L; Wilson M; Byrne E; Hollywood B; O'Kelly F; O'Ciardha D
    Ir J Med Sci; 2020 May; 189(2):557-561. PubMed ID: 31631243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug test results as a predictor of retention among patients using buprenorphine in a comprehensive outpatient treatment program.
    Campbell MD; Kolodner G; Spencer RA; DuPont RL
    J Addict Dis; 2016; 35(4):315-324. PubMed ID: 26757093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.